Skip to main content
. 2021 Jan 25;3:100057. doi: 10.1016/j.conx.2021.100057

Table 2.

Abortion process reported by women who received telemedicine medical abortion services at 13 or more weeks gestation, by gestational age category

Study population (N = 131)
13-15 weeks (n = 102)
16+ Weeks (n = 29)
n (%) n (%) n (%) p Value
Continued pregnancy <0.01
No 118 (90) 97 (95) 21 (5)
Yes 13 (10) 5 (5) 8 (28)
Type of medical abortion pills 0.73
Misoprostol only 13 (10) 11 (11) 2 (7)
Misoprostol + mifepristone 118 (90) 91 (88) 27 (93)
Adverse event reported (very heavy bleeding/fever) 0.07
Yes 38 (29) 34 (33) 4 (14)
No 32 (24) 23 (22) 9 (31)
Missing 61 (47) 46 (45) 16 (55)
Sought additional care 1.00
Yes 53 (40) 41 (40) 12 (41)
No 22 (17) 17 (17) 5 (17)
Missing 56 (43) 45 (44) 12 (41)
Received D&C, among all
Yes 23 (18) 18 (17) 5 (17)
No/Missing 108 (82) 85 (83) 24 (83)
Received D&C, among care seekers (n = 53)
Yes 23 (43) 18 (44) 5 (42) 1.00
No/Missing 30 (57) 23 (56) 7 (58)
Medical abortion acceptable 0.07
Yes 61 (47) 51 (50) 10 (34)
No 5 (4) 2 (2) 3 (10)
Missing 66 (49) 49 (48) 16 (55)

D&C, dilation and curettage.